Fig. 5From: New agents and regimens for diffuse large B cell lymphomaRecommended treatment for DLBCL. PET positron emission tomography and computed tomography, SCR stem cell rescue, ISRT involved site radiotherapy, CAR chimeric antigen receptor, HCT stem cell transplantation, Pola + BR polatuzumab vedotin combined with bendamustine and rituximabBack to article page